|
|
||||||||
1 Département de Pharmacologie, Faculté de Médecine Paris Sud and Institut National de la Santé et de la Recherche Médicale (INSERM) E00.01, 94276 Le Kremlin-Bicêtre Cedex, France; and 2 INSERM U430, Hôpital Broussais, 75014 Paris, France
We investigated the influence of coronary artery reperfusion (CAR) duration on the infarct-limiting properties of adenosine A1-receptor stimulation-induced delayed preconditioning (A1-DPC) compared with ischemia-induced delayed preconditioning (I-DPC). Sixty-one chronically instrumented conscious rabbits successfully underwent the following protocol. On day 1, rabbits were randomly divided into four groups: control (saline, iv), I-DPC (six 4-min coronary artery occlusion/4-min reperfusion cycles), A1-DPC100 (N6-cyclopentyladenosine, 100 µg/kg iv), and A1-DPC400 (N6-cyclopentyladenosine, 400 µg/kg iv). On day 2 (i.e., 24 h later), rabbits underwent a 30-min coronary artery occlusion after which CAR was started and maintained for either 3 or 72 h. Infarct size (percentage of the area at risk) was determined by triphenyltetrazolium chloride staining. After 3 h of CAR, I-DPC, A1-DPC100, and A1-DPC400 significantly decreased infarct size (36 ± 5, 41 ± 4, 38 ± 5%, respectively) compared with control (55 ± 3%). After 72 h of CAR, infarct sizes were not significantly different among the four groups. This result was confirmed by histologic analysis. Thus A1-DPC at the two investigated doses, as well as I-DPC, decreased infarct size after 3 h but not 72 h of CAR.
ischemia; cardioprotection; N6-cyclopentyladenosine; infarct size
This article has been cited by other articles:
![]() |
K. Aouam, R. Tissier, P. Bruneval, C. Mandet, A. Berdeaux, and B. Ghaleh Preconditioning of salvaged myocardium in conscious rabbits with postinfarction dysfunction Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2763 - H2769. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kristo, Y. Yoshimura, B. J. Keith, R. M. Stevens, S. A. Jahania, R. M. Mentzer Jr., and R. D. Lasley Adenosine A1/A2a receptor agonist AMP-579 induces acute and delayed preconditioning against in vivo myocardial stunning Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2746 - H2753. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |